Anglo-US biotech NodThera has named former Jazz Pharma executive Dan Swisher as its new chief executive, replacing Alan Watt, ...

Spectrum.Life has followed its recent rebrand with a €17 million ($18.5 million) financing that will be used to expand the ...

The Japanese group’s NS Pharma subsidiary has revealed that Viltepso (viltolarsen) missed its primary objective in the ...

Asahi Kasei has offered to buy Sweden’s Calliditas Therapeutics for SEK 11.8 billion ($1.1 billion) as part of a plan to ...

Johnson & Johnson has reached an agreement to acquire a bispecific antibody for atopic dermatitis (AD) from Numab Therapeutics in an all-cash deal valued at $1.25 billion.

Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma ...

Fuelled by new data showing GLP-1 agonists can have benefits beyond diabetes and obesity – including reducing risk in ...

AZ’s head of oncology R&D Susan Galbraith pointed out that Dato-DXd is the only investigational therapy to show a “clinically ...

Lawmakers across the political divide have accused the pharma industry of abusing the patent system to keep the prices of ...

The new funding follows a $63 million Series A completed in 2021, and comes as AltruBio is testing its lead candidate – ...

Regardless of fluctuations in funding, the geopolitical climate, and macroeconomic headwinds, companies in this space are ...

The reason that NICE decided to review Qalsody through the STA route was due to the organisation not considering SOD1 MND a ...